Pyrazinamide Tablets recall: CGMP Deviations
Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.
Why was Pyrazinamide Tablets recalled?
cGMP Deviations
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 19B064A, Exp. Date 03/2022
- Product
- Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.
- Recalling firm
- ANI Pharmaceuticals, Inc.
- Quantity
- 5,477 bottles
- Distribution
- Nationwide within the United States
- Recall date
- February 23, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)